The Pharma Drug Movement Monitoring System as an Object of the Critical Information Infrastructure of the Russian Federation

The Drug Movement Monitoring System was developed in Russia and implemented in Russian pharmaceutical sector to protect citizens from counterfeit and substandard medicines. Purpose: to analyze the legal status and significance of the Drug Movement Monitoring System (MDLP) in the context of Russian legislation on the protection of critical information infrastructure (CII). Methods: empirical descriptions, interpretations; theoretical methods of formal and dialectical logic. The author explores the social, economic, and national systems, analyzes the risks associated with disruptions to its functioning, and assesses the role of the MDLP in ensuring the stability of pharmaceutical supply and safeguarding national security. The study substantiates the necessity of recognizing the MDLP as a first-category CII object by comparing the requirements of the regulatory framework and the results of the risk analysis. The research integrates legal and interdisciplinary approaches, revealing the role of the MDLP within the system of digital state control.